Optical imaging in cancer research: Basic principles, tumor detection, and therapeutic monitoring

Medical Principles and Practice

Volumn 20, Issue 5, 2011, Pages 397-415

  Solomon, Metasebya ^a   Liu, Yang ^a   Berezin, Mikhail Y ^a   Achilefu, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activatable probes; Diffuse optical tomography; Fluorescence lifetime; Image reconstruction; Molecular probe; Near infrared; Photoacoustic imaging; Spectroscopy

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; DEOXYHEMOGLOBIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEMATOPORPHYRIN; INDOCYANINE GREEN; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; APOPTOSIS; AUTOFLUORESCENCE IMAGING; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RESEARCH; CANCER STAGING; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL MICROSCOPY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSE OPTICAL IMAGING; DIFFUSE OPTICAL SPECTROSCOPY; DIFFUSION; ECHO PLANAR IMAGING; ENERGY TRANSFER; EPIFLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FREQUENCY MODULATION; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; LEUKEMIA; LIGHT; LIGHT ABSORPTION; LIGHT EMITTING DIODE; LIGHT SCATTERING; MOLECULAR PROBE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; OXYGEN SATURATION; PHOTOACOUSTIC SPECTROSCOPY; PHOTON; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; TUMOR VASCULARIZATION; UPREGULATION;

BIOMEDICAL RESEARCH; HUMANS; IMAGING, THREE-DIMENSIONAL; MOLECULAR IMAGING; MONITORING, PHYSIOLOGIC; NEOPLASMS; OPTICS AND PHOTONICS; SPECTROSCOPY, NEAR-INFRARED; TUMOR MARKERS, BIOLOGICAL;

EID: 79960504078     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000327655     Document Type: Review

References (183)

1. Hebden JC, Arridge SR, Delpy DT: Optical imaging in medicine. I. Experimental techniques. Phys Med Biol 1997; 42: 825-840. (Pubitemid 27263503) (Pubitemid 27263503)
2. Sokolov K, Follen M, Richards-Kortum R: Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol 2002; 6: 651-658. (Pubitemid 35284197) (Pubitemid 35284197)
3. Tuchin VV: Tissue optics: light scattering methods and instruments for medical diagnosis, ed 2. Bellingham, SPIE Publications, 2007.
4. Vo-Dinh T: Biomedical Photonics Handbook. Boca Raton, CRC Press LLC, 2003.
5. Wang LV: Photoacoustic imaging and spectroscopy. Boca Raton, CRC, 2009.
6. Wax A, Backman V: Biomedical applications of light scattering. New York, McGraw-Hill, 2010.
7. Niemz MH: Laser-tissue interactions: fundamentals and applications, ed 3 enlarged. Berlin, Springer, 2003.
8. Knappe V, Frank F, Rohde E: Principles of lasers and biophotonic effects. Photomed Laser Surg 2004; 22: 411-417. (Pubitemid 39506343) (Pubitemid 39506343)
9. O'Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT: Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol 2010; 220: 317-327.
10. Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, Piwnica-Worms D: Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 2009; 20: 45-53.
11. Yeh AT, Kao BS, Jung WG, Chen ZP, Nelson JS, Tromberg BJ: Imaging wound healing using optical coherence tomography and multiphoton microscopy in an in vitro skinequivalent tissue model. J Biomed Opt 2004; 9: 248-253.
12. Achilefu S: Lighting up tumors with receptor- specific optical molecular probes. Technol Cancer Res Treat 2004; 3: 393-409. (Pubitemid 39096612) (Pubitemid 39096612)
13. Arridge SR: Optical tomography in medical imaging. Inverse Problem 1999; 15:R41-R93.
14. Arridge SR, Hebden JC: Optical imaging in medicine. II. Modelling and reconstruction. Phys Med Biol 1997; 42: 841-853. (Pubitemid 27263504) (Pubitemid 27263504)
15. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, Hasan T: Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010; 110: 2795-2838.
16. Erickson SJ, Godavarty A: Hand-held based near-infrared optical imaging devices: a review. Med Eng Phys 2009; 31: 495-509.
17. Gibson AP, Hebden JC, Arridge SR: Recent advances in diffuse optical imaging. Phys Med Biol 2005; 50:R1-R43. (Pubitemid 40309196) (Pubitemid 40309196)
18. Monsees B, Destouet JM, Gersell D: Light scan evaluation of nonpalpable breast lesions. Radiology 1987; 163: 467-470. (Pubitemid 17068928) (Pubitemid 17068928)
19. Monsees B, Destouet JM, Totty WG: Light scanning versus mammography in breast cancer detection. Radiology 1987; 163: 463-465. (Pubitemid 17068927) (Pubitemid 17068927)
20. Drexler B, Davis JL, Schofield G: Diaphanography in the diagnosis of breast-cancer. Radiology 1985; 157: 41-44.
21. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, Fujimoto JG: Optical coherence tomography. Science 1991; 254: 1178-1181. (Pubitemid 21917444) (Pubitemid 21917444)
22. Boppart SA, Luo W, Marks DL, Singletary KW: Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer. Breast Cancer Res Treat 2004; 84: 85-97. (Pubitemid 38393359) (Pubitemid 38393359)
23. Swanson EA, Izatt JA, Hee MR, Huang D, Lin CP, Schuman JS, Puliafito CA, Fujimoto JG: In-vivo retinal imaging by optical coherence tomography. Opt Lett 1993; 18: 1864-1866.
24. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI: Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009; 2: 1035-1046.
25. Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitris C, Southern JF, Fujimoto JG: In vivo endoscopic optical biopsy with optical coherence tomography. Science 1997; 276: 2037-2039. (Pubitemid 27443607) (Pubitemid 27443607)
26. Badizadegan K, Backman V, Boone CW, Crum CP, Dasari RR, Georgakoudi I, Keefe K, Munger K, Shapshay SM, Sheets EE, Feld MS: Spectroscopic diagnosis and imaging of invisible pre-cancer. Faraday Discuss 2004; 126: 265-279. (Pubitemid 38365599) (Pubitemid 38365599)
27. Flusberg BA, Cocker ED, Piyawattanametha W, Jung JC, Cheung ELM, Schnitzer MJ: Fiber- optic fluorescence imaging. Nat Methods 2005; 2: 941-950. (Pubitemid 43108730) (Pubitemid 43108730)
28. VoDinh T, Panjehpour M, Overholt BF, Buckley P: Laser-induced differential fluorescence for cancer diagnosis without biopsy. Appl Spectrosc 1997; 51: 58-63. (Pubitemid 127638894) (Pubitemid 127638894)
29. Choe R, Corlu A, Lee K, Durduran T, Konecky SD, Grosicka-Koptyra M, Arridge SR, Czerniecki BJ, Fraker DL, DeMichele A, Chance B, Rosen MA, Yodh AG: Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005; 32: 1128-1139. (Pubitemid 40586797) (Pubitemid 40586797)
30. Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E: Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy. Radiology 2010; 254: 277-284.
31. Choe R: Diffuse optical tomography and spectroscopy in breast cancer characterization and therapy monitoring at UPENN (invited paper). Conf Proc IEEE Eng Med Biol Soc 2009; 1: 6335-6337.
32. Villalobos V, Naik S, Piwnica-Worms D: Current state of imaging protein-protein interactions in vivo with genetically encoded reporters. Annu Rev Biomed Eng 2007; 9: 321-349. (Pubitemid 350246660) (Pubitemid 350246660)
33. Hoffman RM: The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005; 5: 796-806. (Pubitemid 41400779) (Pubitemid 41400779)
34. Hoffman RM: Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin Exp Metastasis 2009; 26: 345-355.
35. Boppart SA: Optical coherence tomography - principles, applications and advances. Minerva Biotecnol 2004; 16: 211-237.
36. Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA: Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007; 12: 051403.
37. Gibson AP, Hebden JC, Arridge SR: Recent advances in diffuse optical imaging. Phys Med Biol 2005; 50:R1-R43. (Pubitemid 40309196) (Pubitemid 40309196)
38. Wang LV, Wu H-I: Biomedical Optics: Principles and Imaging, ed 1. Hoboken, Wiley- Interscience, 2007.
39. Xu RX, Povoski SP: Diffuse optical imaging and spectroscopy for cancer. Expert Rev Med Devices 2007; 4: 83-95. (Pubitemid 46157685) (Pubitemid 46157685)
40. Hebden JC, Arridge SR, Delpy DT: Optical imaging in medicine. I. Experimental techniques. Phys Med Biol 1997; 42: 825-840. (Pubitemid 27263503) (Pubitemid 27263503)
41. Chance B, Nioka S, Kent J, McCully K, Fountain M, Greenfeld R, Holtom G: Time-resolved spectroscopy of hemoglobin and myoglobin in resting and ischemic muscle. Anal Biochem 1988; 174: 698-707.
42. Grosenick D, Wabnitz H, Rinneberg HH, Moesta KT, Schlag PM: Development of a time-domain optical mammograph and first in vivo applications. Appl Opt 1999; 38: 2927-2943. (Pubitemid 129306983) (Pubitemid 129306983)
43. Patwardhan S, Bloch S, Achilefu S, Culver J: Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice. Opt Express 2005; 13: 2564-2577.
44. Xu MH, Wang LHV: Photoacoustic imaging in biomedicine. Rev Sci Instruments 2006; 77.
45. Arridge SR, Schotland JC: Optical tomography: forward and inverse problems. Inverse Problem 2009; 2.
46. Arridge SR, Hebden JC: Optical imaging in medicine. II. Modelling and reconstruction. Phys Med Biol 1997; 42: 841-853. (Pubitemid 27263504) (Pubitemid 27263504)
47. Arridge SR, Schweiger M: Image reconstruction in optical tomography. Philos Trans R Soc Lond B Biol Sci 1997; 352: 717-726. (Pubitemid 27354103) (Pubitemid 27354103)
48. Dehghani H, Srinivasan S, Pogue BW, Gibson A: Numerical modelling and image reconstruction in diffuse optical tomography. Philos Transact A Math Phys Eng Sci 2009; 367: 3073-3093.
49. Wang L, Jacques SL, Zheng L: MCML - Monte Carlo modeling of light transport in multilayered tissues. Comput Methods Programs Biomed 1995; 47: 131-146.
50. Patterson MS, Chance B, Wilson BC: Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt 1989; 28: 2331-2336.
51. Gibson A, Dehghani H: Diffuse optical imaging. Philos Transact A Math Phys Eng Sci 2009; 367: 3055-3072.
52. Schweiger M, Arridge SR, Hiraoka M, Delpy DT: The finite element method for the propagation of light in scattering media: boundary and source conditions. Med Phys 1995; 22: 1779-1792.
53. Gaudette RJ, Brooks DH, DiMarzio CA, Kilmer ME, Miller EL, Gaudette T, Boas DA: A comparison study of linear reconstruction techniques for diffuse optical tomographic imaging of absorption coefficient. Phys Med Biol 2000; 45: 1051-1070. (Pubitemid 30196395) (Pubitemid 30196395)
54. Schweiger M, Gibson A, Arridge SR: Computational aspects of diffuse optical tomography. Comput Sci Eng 2003; 5: 33-41.
55. Yalavarthy PK, Pogue BW, Dehghani H, Paulsen KD: Weight-matrix structured regularization provides optimal generalized least-squares estimate in diffuse optical tomography. Med Phys 2007; 34: 2085-2098. (Pubitemid 47055744) (Pubitemid 47055744)
56. Yalavarthy PK, Lynch DR, Pogue BW, Dehghani H, Paulsen KD: Implementation of a computationally efficient least-squares algorithm for highly under-determined threedimensional diffuse optical tomography problems. Med Phys 2008; 35: 1682-1697. (Pubitemid 351614782) (Pubitemid 351614782)
57. Boas DA, Brooks DH, Miller EL, DiMarzio CA, Kilmer M, Gaudette RJ, Zhang Q: Imaging the body with diffuse optical tomography. IEEE Signal Process Mag 2001; 18: 57-75. (Pubitemid 33090780) (Pubitemid 33090780)
58. Correia T, Gibson A, Schweiger M, Hebden J: Selection of regularization parameter for optical topography. J Biomed Opt 2009; 14: 034044.
59. Schweiger M, Arridge SR, Nissila I: Gauss- Newton method for image reconstruction in diffuse optical tomography. Phys Med Biol 2005; 50: 2365-2386. (Pubitemid 40767821) (Pubitemid 40767821)
60. Ntziachristos V, Turner G, Dunham J, Windsor S, Soubret A, Ripoll J, Shih HA: Planar fluorescence imaging using normalized data. J Biomed Opt 2005; 10: 064007.
61. Hyde D, Miller E, Brooks DH, Ntziachristos V: A statistical approach to inverting the born ratio. IEEE Trans Med Imaging 2007; 26: 893-905. (Pubitemid 47147237) (Pubitemid 47147237)
62. Ntziachristos V, Weissleder R: Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized born approximation. Opt Lett 2001; 26: 893-895. (Pubitemid 33693607) (Pubitemid 33693607)
63. Gabor D: A new microscopic principle. Nature 1948; 161: 777.
64. Srinivasan V, Liu HC, Halioua M: Automated phase-measuring profilometry of 3-D diffuse objects. Appl Opt 1984; 23: 3105.
65. Gioux S, Mazhar A, Cuccia DJ, Durkin AJ, Tromberg BJ, Frangioni JV: Three-dimensional surface profile intensity correction for spatially modulated imaging. J Biomed Opt 2009; 14: 034045.
66. Takeda M, Mutoh K: Fourier transform profilometry for the automatic measurement of 3-D object shapes. Appl Opt 1983; 22: 3977.
67. Ramanujam N, Mitchell MF, Mahadevan A, Thomsen S, Silva E, Richards-Kortum R: Fluorescence spectroscopy: a diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynecol Oncol 1994; 52: 31-38. (Pubitemid 24066849) (Pubitemid 24066849)
68. Richards-Kortum R, Sevick-Muraca E: Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 1996; 47: 555-606. (Pubitemid 126416975) (Pubitemid 126416975)
69. Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE: Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008; 35: 2443-2451. (Pubitemid 351748652) (Pubitemid 351748652)
70. Vishwanath K, Klein D, Chang K, Schroeder T, Dewhirst MW, Ramanujam N: Quantitative optical spectroscopy can identify longterm local tumor control in irradiated murine head and neck xenografts. J Biomed Opt 2009; 14: 054051.
71. Kukreti S, Cerussi A, Tromberg B, Gratton E: Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra. J Biomed Opt 2007; 12: 020509.
72. Kukreti S, Cerussi A, Tromberg B, Gratton E: Intrinsic near-infrared spectroscopic markers of breast tumors. Dis Markers 2008; 25: 281-290.
73. Vishwanath K, Yuan H, Barry WT, Dewhirst MW, Ramanujam N: Using optical spectroscopyto longitudinally monitor physiological changes within solid tumors. Neoplasia 2009; 11: 889-900.
74. Palmer GM, Boruta RJ, Viglianti BL, Lan L, Spasojevic I, Dewhirst MW: Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy. J Control Release 2010; 142: 457-464.
75. Cerussi AE, Tanamai VW, Mehta RS, Hsiang D, Butler J, Tromberg BJ: Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol 2010; 17: 1031-1039.
76. Choe R, Konecky SD, Corlu A, Lee K, Durduran T, Busch DR, Pathak S, Czerniecki BJ, Tchou J, Fraker DL, Demichele A, Chance B, Arridge SR, Schweiger M, Culver JP, Schnall MD, Putt ME, Rosen MA, Yodh AG: Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallelplate diffuse optical tomography. J Biomed Opt 2009; 14: 024020.
77. Patwardhan SV, Bloch S, Achilefu S, Culver JP: Quantitative small animal fluorescence tomography using an ultrafast gated image intensifier. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 2675-2678. (Pubitemid 46520459) (Pubitemid 46520459)
78. Patwardhan SV, Culver JP: Quantitative diffuse optical tomography for small animals using an ultrafast gated image intensifier. J Biomed Opt 2008; 13: 011009.
79. Ntziachristos V, Tung CH, Bremer C, Weissleder R: Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8: 757-760. (Pubitemid 34778731) (Pubitemid 34778731)
80. Ntziachristos V, Bremer C, Weissleder R: Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003; 13: 195-208. (Pubitemid 36790510) (Pubitemid 36790510)
81. Pogue BW, Gibbs SL, Chen B, Savellano M: Fluorescence imaging in vivo: raster scanned point-source imaging provides more accurate quantification than broad beam geometries. Technol Cancer Res Treat 2004; 3: 15-21. (Pubitemid 38250464) (Pubitemid 38250464)
82. Berezin MY, Lee H, Akers W, Guo K, Goiffon RJ, Almutairi A, Frechet JM, Achilefu S: Engineering NIR dyes for fluorescent lifetime contrast. Conf Proc IEEE Eng Med Biol Soc 2009; 1: 114-117.
83. Nothdurft RE, Patwardhan SV, Akers W, Ye Y, Achilefu S, Culver JP: In vivo fluorescence lifetime tomography. J Biomed Opt 2009; 14: 024004.
84. Bloch S, Lesage F, McIntosh L, Gandjbakhche A, Liang K, Achilefu S: Whole-body fluorescence lifetime imaging of a tumortargeted near-infrared molecular probe in mice. J Biomed Opt 2005; 10: 054003.
85. Berezin MY, Achilefu S: Fluorescence lifetime measurements and biological imaging. Chem Rev 2010; 110: 2641-2684.
86. Berezin MY, Lee H, Akers W, Nikiforovich G, Achilefu S: Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near-infrared fluorescent molecular probes. Photochem Photobiol 2007; 83: 1371-1378. (Pubitemid 350132604) (Pubitemid 350132604)
87. Cubeddu R, Canti G, Taroni P, Valentini G: Time-gated luorescence imaging for the diagnosis of tumors in a murine model. Photochem Photobiol 1993; 57: 480-485.
88. Cubeddu R, Canti G, Pifferi A, Taroni P, Valentini G: Fluorescence lifetime imaging of experimental tumors in hematoporphyrin derivative-sensitized mice. Photochem Photobiol 1997; 66: 229-236. (Pubitemid 127470171) (Pubitemid 127470171)
89. Andersson-Engels S, Canti G, Cubeddu R, Eker C, af Klinteberg C, Pifferi A, Svanberg K, Svanberg S, Taroni P, Valentini G, Wang I: Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin. Lasers Surg Med 2000; 26: 76-82. (Pubitemid 30054275) (Pubitemid 30054275)
90. Reynolds JS, Troy TL, Mayer RH, Thompson AB, Waters DJ, Cornell KK, Snyder PW, Sevick- Muraca EM: Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol 1999; 70: 87-94. (Pubitemid 129572619) (Pubitemid 129572619)
91. Akers W, Lesage F, Holten D, Achilefu S: In vivo resolution of multiexponential decays of multiple near-infrared molecular probes by fluorescence lifetime-gated whole-body time-resolved diffuse optical imaging. Mol Imaging 2007; 6: 237-246. (Pubitemid 47509828) (Pubitemid 47509828)
92. Raymond SB, Boas DA, Bacskai BJ, Kumar AT: Lifetime-based tomographic multiplexing. J Biomed Opt 2010; 15: 046011.
93. Maslov K, Stoica G, Wang LV: In vivo darkfield reflection-mode photoacoustic microscopy. Opt Lett 2005; 30: 625-627. (Pubitemid 40402333) (Pubitemid 40402333)
94. Zhang HF, Maslov K, Wang LV: In vivo imaging of subcutaneous structures using functional photoacoustic microscopy. Nat Protoc 2007; 2: 797-804. (Pubitemid 46745576) (Pubitemid 46745576)
95. Li ML, Zhang HE, Maslov K, Stoica G, Wang LV: Improved in vivo photoacoustic microscopy based on a virtual-detector concept. Opt Lett 2006; 31: 474-476.
96. Kim C, Favazza C, Wang LV: In vivo photoacoustic tomography of chemicals: highresolution functional and molecular optical imaging at new depths. Chem Rev 2010; 110: 2756-2782.
97. Kim G, Huang SW, Day KC, O'Donnell M, Agayan RR, Day MA, Kopelman R, Ashkenazi S: Indocyanine-green-embedded pebbles as a contrast agent for photoacoustic imaging. J Biomed Opt 2007; 12: 044020.
98. Homan K, Kim S, Chen YS, Wang B, Mallidi S, Emelianov S: Prospects of molecular photoacoustic imaging at 1064 nm wavelength. Opt Lett 2010; 35: 2663-2665.
99. Achilefu SI, Bornhop DJ, Raghavachari R: Society of Photo-optical Instrumentation Engineers: Optical Molecular Probes for Biomedical Applications, San Jose, January 2006. Bellingham, SPIE, 2006.
100. Akers WJ, Kim C, Berezin M, Guo K, Fuhrhop R, Lanza GM, Fischer GM, Daltrozzo E, Zumbusch A, Cai X, Wang LV, Achilefu S: Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles. ACS Nano 2011; 25: 173-182.
101. Pramanik M, Ku G, Li C, Wang LV: Design and evaluation of a novel breast cancer detection system combining both thermoacoustic (TA) and photoacoustic (PA) tomography. Med Phys 2008; 35: 2218-2223. (Pubitemid 351752941) (Pubitemid 351752941)
102. Manohar S, Kharine A, van Hespen JC, Steenbergen W, van Leeuwen TG: Photoacoustic mammography laboratory prototype: imaging of breast tissue phantoms. J Biomed Opt 2004; 9: 1172-1181. (Pubitemid 40168131) (Pubitemid 40168131)
103. Kim C, Erpelding TN, Maslov K, Jankovic L, Akers WJ, Song LA, Achilefu S, Margenthaler JA, Pashley MD, Wang LHV: Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes. J Biomed Opt 2010; 15: 046010.
104. Galanzha EI, Kokoska MS, Shashkov EV, Kim JW, Tuchin VV, Zharov VP: In vivo fiber-based multicolor photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles. J Biophotonics 2009; 2: 528-539.
105. Staley J, Grogan P, Samadi AK, Cui H, Cohen MS, Yang X: Growth of melanoma brain tumors monitored by photoacoustic microscopy. J Biomed Opt 2010; 15: 040510.
106. Pan D, Pramanik M, Senpan A, Allen JS, Zhang H, Wickline SA, Wang LV, Lanza GM: Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons. FASEB J 2011; 25: 875-882.
107. Jose J, Manohar S, Kolkman RGM, Steenbergen W, van Leeuwen TG: Imaging of tumor vasculature using Twente photoacoustic systems. J Biophotonics 2009; 2: 701-717.
108. Galanzha EI, Shashkov EV, Spring PM, Suen JY, Zharov VP: In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res 2009; 69: 7926-7934.
109. Olafsson R, Bauer DR, Montilla LG, Witte RS: Real-time, contrast enhanced photoacoustic imaging of cancer in a mouse window chamber. Opt Express 2010; 18: 18625-18632.
110. Kim C, Cho EC, Chen J, Song KH, Au L, Favazza C, Zhang Q, Cobley CM, Gao F, Xia Y, Wang LV: In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano 2010; 4: 4559-4564.
111. Song L, Kim C, Maslov K, Shung KK, Wang LV: High-speed dynamic 3D photoacoustic imaging of sentinel lymph node in a murine model using an ultrasound array. Med Phys 2009; 36: 3724-3729.
112. Song KH, Kim C, Maslov K, Wang LV: Noninvasive in vivo spectroscopic nanorodcontrast photoacoustic mapping of sentinel lymph nodes. Eur J Radiol 2009; 70: 227-231.
113. Song KH, Stein EW, Margenthaler JA, Wang LV: Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model. J Biomed Opt 2008; 13: 054033.
114. Pramanik M, Song KH, Swierczewska M, Green D, Sitharaman B, Wang LV: In vivo carbon nanotube-enhanced non-invasive photoacoustic mapping of the sentinel lymph node. Phys Med Biol 2009; 54: 3291-3301.
115. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP: In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol 2009; 4: 855-860.
116. Leff DR, Warren OJ, Enfield LC, Gibson A, Athanasiou T, Patten DK, Hebden J, Yang GZ, Darzi A: Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Res Treat 2008; 108: 9-22. (Pubitemid 351623242) (Pubitemid 351623242)
117. Monici M: Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev 2005; 11: 227-256. (Pubitemid 41510279) (Pubitemid 41510279)
118. Zhu C, Palmer GM, Breslin TM, Harter J, Ramanujam N: Diagnosis of breast cancer using fluorescence and diffuse reflectance spectroscopy: a Monte-Carlo-model-based approach. J Biomed Opt 2008; 13: 034015.
119. Imaeda H, Hosoe N, Kashiwagi K, Ida Y, Saito Y, Suzuki H, Aiura K, Ogata H, Kumai K, Hibi T: Autofluorescence videoendoscopy system using the SAFE-3000 for assessing superficial gastric neoplasia. J Gastroenterol Hepatol 2010; 25: 706-711.
120. Falk GW: Autofluorescence endoscopy. Gastrointest Endosc Clin N Am 2009; 19: 209-220.
121. Bhaumik S, Depuy J, Klimash J: Strategies to minimize background autofluorescence in live mice during noninvasive fluorescence optical imaging. Lab Anim 2007; 36: 40-43. (Pubitemid 47326741) (Pubitemid 47326741)
122. Bouchard MB, MacLaurin SA, Dwyer PJ, Mansfield J, Levenson R, Krucker T: Technical considerations in longitudinal multispectral small animal molecular imaging. J Biomed Opt 2007; 12: 051601.
123. Akers WJ, Achilefu S: Optical molecular imaging; in Boas DA, Pitris C, Ramanujam N (eds): Handbook of Biomedical Optics. Boca Raton, CRC Press, 2010.
124. Licha K, Hessenius C, Becker A, Henklein P, Bauer M, Wisniewski S, Wiedenmann B, Semmler W: Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptortargeted fluorescent probes. Bioconjug Chem 2001; 12: 44-50. (Pubitemid 32111452) (Pubitemid 32111452)
125. Licha K, Riefke B, Ntziachristos V, Becker A, Chance B, Semmler W: Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem Photobiol 2000; 72: 392-398.
126. Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B: In vivo continuous-wave optical breast imaging enhanced with indocyanine green. Med Phys 2003; 30: 1039-1047. (Pubitemid 36735969) (Pubitemid 36735969)
127. Alacam B, Yazici B, Intes X, Chance B: Analysis of ICG Pharmacokinetics in Cancerous Tumors using NIR Optical Methods. Conf Proc IEEE Eng Med Biol Soc 2005; 1: 62-65. (Pubitemid 46228793) (Pubitemid 46228793)
128. Alacam B, Yazici B, Intes X, Nioka S, Chance B: Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol 2008; 53: 837-859. (Pubitemid 351238109) (Pubitemid 351238109)
129. Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blanchard DK, Fisher RE, Chiang SB, Elledge R, Mawad ME: Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 2008; 246: 734-741.
130. Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005; 5: 845-856. (Pubitemid 41746029) (Pubitemid 41746029)
131. Sidransky D: Emerging molecular markers of cancer. Nat Rev Cancer 2002; 2: 210-219. (Pubitemid 37328790) (Pubitemid 37328790)
132. Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R: Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol 2000; 35: 479-485. (Pubitemid 30622015) (Pubitemid 30622015)
133. Ballou B, Fisher GW, Deng JS, Hakala TR, Srivastava M, Farkas DL: Cyanine fluorochrome- labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect Prev 1998; 22: 251-257. (Pubitemid 28226758) (Pubitemid 28226758)
134. Clauss MA, Jain RK: Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. Cancer Res 1990; 50: 3487-3492. (Pubitemid 20194084) (Pubitemid 20194084)
135. Ross JS, Fletcher JA: HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 1999; 112(suppl 1):S53-S67. (Pubitemid 30219464) (Pubitemid 30219464)
136. Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Symmans WF, Pusztai L, Hortobagyi GN: Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics 2004; 3: 379-398. (Pubitemid 38702091) (Pubitemid 38702091)
137. Nicholson S, Richard J, Sainsbury C, Halcrow P, Kelly P, Angus B, Wright C, Henry J, Farndon JR, Harris AL: Epidermal growth factor receptor (EGFR): results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 1991; 63: 146-150.
138. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 1999; 17: 2639-2648. (Pubitemid 29415219) (Pubitemid 29415219)
139. Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Hortobagyi GN: HER-2/neu testing in breast cancer. Am J Clin Pathol 2003; 120(suppl):S53-S71.
140. Vogel C, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ: First-line, single-agent herceptin (trastuzumab) in metastatic breast cancer: a preliminary report. Eur J Cancer 2001; 37(suppl 1):S25-S29.
141. Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H: Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 2007; 13: 2936-2945. (Pubitemid 46849568) (Pubitemid 46849568)
142. Sampath L, Kwon S, Hall MA, Price RE, Sevick- Muraca EM: Detection of cancer metastases with a dual-labeled near-infrared/ positron emission tomography imaging agent. Transl Oncol 2010; 3: 307-317.
143. Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL: Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptidebased optical contrast agents. J Med Chem 2002; 45: 2003-2015. (Pubitemid 34477714) (Pubitemid 34477714)
144. Giancotti FG: Complexity and specificity of integrin signalling. Nat Cell Biol 2000; 2:E13-E14.
145. Giancotti FG: Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997; 9: 691-700. (Pubitemid 27424926) (Pubitemid 27424926)
146. Giancotti FG, Ruoslahti E: Transductionintegrin signaling. Science 1999; 285: 1028-1032.
147. Guo WJ, Giancotti FG: Integrin signaling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816-826.
148. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309: 30-33. (Pubitemid 14134132) (Pubitemid 14134132)
149. Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, Becker KF, Goebel M, Hein R, Wester HJ, Kessler H, Schwaiger M: Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F] galacto-RGD. PLoS Med 2005; 2:e70.
150. Achilefu S, Bloch S, Markiewicz MA, Zhong T, Ye Y, Dorshow RB, Chance B, Liang K: Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci USA 2005; 102: 7976-7981. (Pubitemid 40781048) (Pubitemid 40781048)
151. Bloch S, Xu B, Ye Y, Liang K, Nikiforovich GV, Achilefu S: Targeting beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe. Mol Pharm 2006; 3: 539-549. (Pubitemid 44639131) (Pubitemid 44639131)
152. Ye Y, Bloch S, Xu B, Achilefu S: Design, synthesis, and evaluation of near infrared fluorescentmultimeric RGD peptides for targeting tumors. J Med Chem 2006; 49: 2268-2275.
153. Hsiung PL, Hardy J, Friedland S, Soetikno R, Du CB, Wu AP, Sahbaie P, Crawford JM, Lowe AW, Contag CH, Wang TD: Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med 2008; 14: 454-458. (Pubitemid 351499384) (Pubitemid 351499384)
154. Lee H, Akers WJ, Cheney PP, Edwards WB, Liang K, Culver JP, Achilefu S: Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe. J Biomed Opt 2009; 14: 040507.
155. McIntyre JO, Matrisian LM: Molecular imaging of proteolytic activity in cancer. J Cell Biochem 2003; 90: 1087-1097. (Pubitemid 37485047) (Pubitemid 37485047)
156. McIntyre JO, Matrisian LM: Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods Mol Biol 2009; 539: 155-174.
157. McIntyre JO, Scherer RL, Matrisian LM: Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods Mol Biol 2010; 622: 279-304.
158. Zhang Z, Fan J, Cheney PP, Berezin MY, Edwards WB, Akers WJ, Shen D, Liang K, Culver JP, Achilefu S: Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. Mol Pharm 2009; 6: 416-427.
159. Paulick MG, Bogyo M: Application of activity- based probes to the study of enzymes involved in cancer progression. Curr Opin Genet Dev 2008; 18: 97-106. (Pubitemid 351694441) (Pubitemid 351694441)
160. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ: Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994-1995; 14: 246-258.
161. Fingleton B: Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects. Expert Opin Ther Targets 2003; 7: 385-397. (Pubitemid 36722223) (Pubitemid 36722223)
162. Duffy MJ: Proteases as prognostic markers in cancer. Clin Cancer Res 1996; 2: 613-618. (Pubitemid 26133464) (Pubitemid 26133464)
163. Liotta LA, Thorgeirsson UP, Garbisa S: Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1982; 1: 277-288.
164. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr: In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999; 17: 375-378. (Pubitemid 29166041) (Pubitemid 29166041)
165. Bremer C, Bredow S, Mahmood U, Weissleder R, Tung CH: Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 2001; 221: 523-529. (Pubitemid 33043440) (Pubitemid 33043440)
166. Bremer C, Tung CH, Weissleder R: In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001; 7: 743-748. (Pubitemid 32588033) (Pubitemid 32588033)
167. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M: Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 2007; 3: 668-677. (Pubitemid 47417706) (Pubitemid 47417706)
168. Gocheva V, Zeng W, Ke DX, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA: Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006; 20: 543-556. (Pubitemid 43345321) (Pubitemid 43345321)
169. Odonkor CA, Achilefu S: Differential activity of caspase-3 regulates susceptibility of lung and breast tumor cell lines to paclitaxel. Open Biochem J 2008; 2: 121-128.
170. Odonkor CA, Achilefu S: Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy. Cancer Invest 2009; 27: 417-429.
171. Bullok K, Piwnica-Worms D: Synthesis and characterization of a small, membranepermeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 2005; 48: 5404-5407. (Pubitemid 41209236) (Pubitemid 41209236)
172. Bullok KE, Maxwell D, Kesarwala AH, Gammon S, Prior JL, Snow M, Stanley S, Piwnica-Worms D: Biochemical and in vivo characterization of a small, membrane- permeant, caspase-activatable farred fluorescent peptide for imaging apoptosis. Biochemistry 2007; 46: 4055-4065. (Pubitemid 46536069) (Pubitemid 46536069)
173. Ntziachristos V, Yodh AG, Schnall MD, Chance B: MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002; 4: 347-354. (Pubitemid 34755845) (Pubitemid 34755845)
174. Zhu Q, Kurtzma SH, Hegde P, Tannenbaum S, Kane M, Huang M, Chen NG, Jagjivan B, Zarfos K: Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia 2005; 7: 263-270. (Pubitemid 40411638) (Pubitemid 40411638)
175. McCann CM, Waterman P, Figueiredo JL, Aikawa E, Weissleder R, Chen JW: Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy. Neuroimage 2009; 45: 360-369.
176. Zhu Q, Tannenbaum S, Kurtzman SH: Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring. Surg Oncol Clin N Am 2007; 16: 307-321. (Pubitemid 46874223) (Pubitemid 46874223)
177. Gulsen G, Yu H, Wang J, Nalcioglu O, Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ: Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors. Technol Cancer Res Treat 2002; 1: 497-505. (Pubitemid 36548526) (Pubitemid 36548526)
178. Culver J, Akers W, Achilefu S: Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med 2008; 49: 169-172. (Pubitemid 351225675) (Pubitemid 351225675)
179. Zhang Q, Brukilacchio TJ, Li A, Stott JJ, Chaves T, Hillman E, Wu T, Chorlton M, Rafferty E, Moore RH, Kopans DB, Boas DA: Coregistered tomographic X-ray and optical breast imaging: initial results. J Biomed Opt 2005; 10: 024033.
180. Edwards WB, Akers WJ, Ye Y, Cheney PP, Bloch S, Xu B, Laforest R, Achilefu S: Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and singlephoton emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide. Mol Imaging 2009; 8: 101-110.
181. Berezin MY, Guo K, Teng B, Edwards WB, Anderson CJ, Vasalatiy O, Gandjbakhche A, Griffiths GL, Achilefu S: Radioactivity- synchronized fluorescence enhancement using a radionuclide fluorescencequenched dye. J Am Chem Soc 2009; 131: 9198-9200.
182. Guo K, Berezin MY, Zheng J, Akers W, Lin F, Teng B, Vasalatiy O, Gandjbakhche A, Griffiths GL, Achilefu S: Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging. Chem Commun (Camb) 2010; 46: 3705-3707.
183. Li A, Miller EL, Kilmer ME, Brukilacchio TJ, Chaves T, Stott J, Zhang Q, Wu T, Chorlton M, Moore RH, Kopans DB, Boas DA: Tomographic optical breast imaging guided by three-dimensional mammography. Appl Opt 2003; 42: 5181-5190.